click below
click below
Normal Size Small Size show me how
Pharmacology Chapt 1
Test 1 Ch. 1
Question | Answer |
---|---|
Biologics | Substances that produce biologic responses within the body; they are synthesized by cells of the human body, animal cells, or microorganisms. |
Clinical investigation | Second stage of drug testing that involves clinical phase trials. |
Clinical phase trials | Testing of a new drug in selected patients. |
Complementary and alternative therapies | Treatments considered outside the realm of conventional Western medicine. |
Drug | General term for any substance capable of producing biologic responses in the body. |
FDA's Critical Path Initiative | National strategy for transforming the way FDA-regulated products are developed, evaluated, manufactured, and used. |
Food and Drug Administration (FDA) | U.S. agency responsible for the evaluation and approval of new drugs. |
Formulary | List of drugs and drug recipes commonly used by pharmacists. |
Investigational New Drug Application (IND) | Application to the FDA that contains all the animal and cell testing data. |
Medication | Drug after it has been administered. |
NDA review | Third stage of new drug evaluation by the FDA. |
Pharmacology | The study of medicines; the discipline pertaining to how drugs improve or maintain health. |
Pharmacopoeia | Medical reference indicating standards of drug purity, strength, and directions for synthesis. |
Pharmacotherapy | Treatment or prevention of disease by means of drugs. |
Postmarketing surveillance | Evaluation of a new drug after it has been approved and used in large numbers of patients. |
Preclinical investigation | Procedure implemented after a drug has been licensed for public use, designed to provide information on use and on occurrence of side effects. |
Therapeutics | The branch of medicine concerned with the treatment of disease and suffering. |